Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Transmedics Group Inc (TMDX)

Transmedics Group Inc (TMDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 427,420
  • Shares Outstanding, K 27,155
  • Annual Sales, $ 23,600 K
  • Annual Income, $ -33,550 K
  • 60-Month Beta 1.83
  • Price/Sales 18.96
  • Price/Cash Flow N/A
  • Price/Book 3.09

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.32
  • Number of Estimates 4
  • High Estimate -0.28
  • Low Estimate -0.37
  • Prior Year -0.39
  • Growth Rate Est. (year over year) +17.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.69 +0.32%
on 09/18/20
18.77 -16.14%
on 08/19/20
-2.31 (-12.80%)
since 08/18/20
3-Month
15.69 +0.32%
on 09/18/20
19.57 -19.57%
on 08/06/20
-1.09 (-6.48%)
since 06/18/20
52-Week
10.10 +55.84%
on 03/17/20
25.30 -37.79%
on 09/20/19
-8.60 (-35.33%)
since 09/18/19

Most Recent Stories

More News
TransMedics to Present at the 18th Annual Morgan Stanley Global Healthcare Conference

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, announced today...

MS : 50.08 (-0.34%)
TMDX : 15.74 (-4.49%)
TransMedics: 2Q Earnings Snapshot

ANDOVER, Mass. (AP) _ TransMedics Group Inc. (TMDX) on Wednesday reported a loss of $8.5 million in its second quarter.

TMDX : 15.74 (-4.49%)
TransMedics Reports Second Quarter 2020 Financial Results

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today reported...

TMDX : 15.74 (-4.49%)
3 Medical Product Stocks Set to Beat This Earnings Season

Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.

RMD : 170.01 (-1.67%)
ABT : 106.86 (+0.19%)
TMO : 429.05 (-0.90%)
EXAS : 77.47 (+3.45%)
TNDM : 106.40 (-0.37%)
TMDX : 15.74 (-4.49%)
HCAT : 36.02 (+0.87%)
TransMedics Announces Pricing of Public Offering of Common Stock

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, announced today...

TMDX : 15.74 (-4.49%)
TransMedics Announces Proposed Public Offering of Common Stock

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, announced today...

JPM : 98.35 (-0.21%)
TMDX : 15.74 (-4.49%)
TransMedics Announces Positive Top-line Results from U.S. Pivotal OCS(TM) Liver PROTECT Trial

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today reported...

TMDX : 15.74 (-4.49%)
TransMedics: 1Q Earnings Snapshot

ANDOVER, Mass. (AP) _ TransMedics Group Inc. (TMDX) on Wednesday reported a loss of $8.9 million in its first quarter.

TMDX : 15.74 (-4.49%)
TransMedics Reports First Quarter 2020 Financial Results

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today reported...

TMDX : 15.74 (-4.49%)
TransMedics to Report First Quarter 2020 Financial Results on May 6, 2020

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced...

TMDX : 15.74 (-4.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade TMDX with:

Business Summary

TransMedics Inc. is a commercial-stage medical technology company. It is engaged in transforming organ transplant therapy for end-stage organ failure patients. The company offers Organ Care System, an integrated, compact, portable preservation technology which addresses unmet need for organs for transplantation....

See More

Key Turning Points

2nd Resistance Point 17.35
1st Resistance Point 16.54
Last Price 15.74
1st Support Level 15.31
2nd Support Level 14.89

See More

52-Week High 25.30
Fibonacci 61.8% 19.49
Fibonacci 50% 17.70
Fibonacci 38.2% 15.91
Last Price 15.74
52-Week Low 10.10

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar